NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,393 | +13.7% | 2,792 | +12.7% | 0.04% | +15.6% |
| Q2 2023 | $250,055 | +0.2% | 2,478 | -8.7% | 0.03% | -5.9% |
| Q1 2023 | $249,596 | +15.6% | 2,713 | +14.0% | 0.03% | +9.7% |
| Q4 2022 | $215,823 | +15.4% | 2,379 | +7.5% | 0.03% | +29.2% |
| Q2 2022 | $187,000 | -8.8% | 2,212 | +1.7% | 0.02% | -17.2% |
| Q4 2020 | $205,000 | +29.7% | 2,174 | +32.3% | 0.03% | +7.4% |
| Q1 2019 | $158,000 | +2.6% | 1,643 | -8.7% | 0.03% | -15.6% |
| Q4 2018 | $154,000 | +3.4% | 1,799 | +3.9% | 0.03% | +28.0% |
| Q3 2018 | $149,000 | +13.7% | 1,731 | 0.0% | 0.02% | +4.2% |
| Q2 2018 | $131,000 | +10.1% | 1,731 | +17.4% | 0.02% | +9.1% |
| Q1 2018 | $119,000 | -4.0% | 1,474 | 0.0% | 0.02% | -4.3% |
| Q4 2017 | $124,000 | – | 1,474 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |